Validations: Tech Transfer & Scale-Up Validation

Supply Chain Impacts Post-Launch: Materials and Suppliers

Supply Chain Impacts Post-Launch: Materials and Suppliers In the complex landscape of pharmaceutical manufacturing, understanding the implications of supply chain disruptions post-launch is paramount. This tutorial serves as a comprehensive guide to navigate the challenges associated with the ongoing management of materials and suppliers after a product has entered the market. It will cover essential aspects of continued process verification…

Continue Reading Supply Chain Impacts Post-Launch: Materials and Suppliers

Human Performance After Transfers: Training and Effectiveness

Human Performance After Transfers: Training and Effectiveness Human Performance After Transfers: Training and Effectiveness Introduction to Human Performance in Pharmaceutical Transfers The pharmaceutical industry continually evolves, particularly in the areas of technology transfer and process validation. Ensuring human performance after transfers—be it of personnel or processes—is crucial to maintain product quality and regulatory compliance. This article provides a comprehensive guide…

Continue Reading Human Performance After Transfers: Training and Effectiveness

CPV Handover Package: Parameters, Attributes, and Charts

CPV Handover Package: Parameters, Attributes, and Charts The transition from the validation phase to routine operations in pharmaceutical manufacturing is critical for ensuring product quality and compliance with regulatory expectations. The Continued Process Verification (CPV) Handover Package serves as a formal transfer of knowledge and documents necessary to maintain the robustness of the manufacturing process. This article provides a comprehensive…

Continue Reading CPV Handover Package: Parameters, Attributes, and Charts

US-Focused CPV Limits: Derivation from PPQ/Development Data

US-Focused CPV Limits: Derivation from PPQ/Development Data Continued process verification (CPV) is an essential component of pharmaceutical validation, particularly during the Post-Launch Stabilization phase. This guide offers a comprehensive analysis of how CPV limits can be derived from Process Performance Qualification (PPQ) and development data according to regulatory expectations, including those outlined by the FDA, EMA, and MHRA. This article…

Continue Reading US-Focused CPV Limits: Derivation from PPQ/Development Data

Signal Libraries: Alert/Action Triggers That Work

Signal Libraries: Alert/Action Triggers That Work Signal Libraries: Alert/Action Triggers That Work In the realm of pharmaceutical validation, the establishment of robust signal libraries is paramount, especially in the context of continued process validation (CPV). These libraries serve as critical components in monitoring manufacturing processes and ensuring they remain within defined parameters. This tutorial provides a step-by-step guide for pharmaceutical…

Continue Reading Signal Libraries: Alert/Action Triggers That Work

CPV Dashboards: Visuals for Management Review

CPV Dashboards: Visuals for Management Review CPV Dashboards: Visuals for Management Review Introduction to Continued Process Verification (CPV) Continued Process Verification (CPV) is a critical concept that extends beyond the traditional dimensions of process validation, particularly within the pharmaceutical industry. The FDA emphasizes the importance of CPV in its guideline for process validation, which underscores maintaining product quality over time….

Continue Reading CPV Dashboards: Visuals for Management Review

Re-Qualification Triggers After Transfer: Evidence and Timing

Re-Qualification Triggers After Transfer: Evidence and Timing Introduction to Re-Qualification in Pharmaceutical Validation In the evolving landscape of pharmaceutical production, maintaining compliance with regulatory standards is paramount. Re-qualification processes are essential to the overall quality assurance framework, especially after a technology transfer. The health authorities, including the FDA, the European Medicines Agency (EMA), and the Medicines and Healthcare products Regulatory…

Continue Reading Re-Qualification Triggers After Transfer: Evidence and Timing

Dissolution Transfer: Apparatus, Media, and Profiles

Dissolution Transfer: Apparatus, Media, and Profiles 1. Introduction to Dissolution Transfer Dissolution transfer is an integral part of the pharmaceutical lifecycle, especially during the analytical transfer and method bridging phases. It ensures that dissolution methods are appropriately validated and that results from different laboratories or sites are consistent, reliable, and reproducible. In this tutorial, professionals in pharmaceutical development, quality assurance,…

Continue Reading Dissolution Transfer: Apparatus, Media, and Profiles

Stability-Indicating Methods: Transfer & Ongoing Verification

Stability-Indicating Methods: Transfer & Ongoing Verification Stability-Indicating Methods: Transfer & Ongoing Verification In the pharmaceutical industry, the reliability of analytical methods is crucial for ensuring product quality and compliance with regulatory standards. Stability-indicating methods play a key role in providing data that supports the determination of a product’s shelf life by monitoring the effects of time, temperature, humidity, and light…

Continue Reading Stability-Indicating Methods: Transfer & Ongoing Verification

Techniques Parity: Detector Types, Flow Cells, and Noise

Techniques Parity: Detector Types, Flow Cells, and Noise Techniques Parity: Detector Types, Flow Cells, and Noise Introduction to Analytical Transfer In the realm of pharmaceuticals, ensuring successful analytical transfer is crucial to maintain regulatory compliance and deliver high-quality products. Parsing the complexities of analytical and bioanalytical method transfers requires a thorough understanding of the methodologies, validation processes, and regulatory frameworks…

Continue Reading Techniques Parity: Detector Types, Flow Cells, and Noise